Related Experiment Videos
[Serological character of hepatitis E virus mutants]
1National Institute for the Control of Pharmaceutical and Biological Products, Beijing.
Summary
Hepatitis E virus (HEV) mutants were detected in sera, but standard antibody tests failed to identify them. This highlights limitations in current diagnostics for emerging HEV strains.
Area of Science:
- Virology
- Hepatology
- Immunology
Context:
- Hepatitis E virus (HEV) is an emerging pathogen with diverse genotypes.
- Serological assays are crucial for diagnosing HEV infections.
- Non-A-E hepatitis cases require etiological investigation.
Purpose:
- To detect HEV RNA in serologically negative non-A-E hepatitis cases.
- To characterize the genetic and serological features of detected HEV strains.
- To evaluate the efficacy of commercial anti-HEV enzyme immunoassay (EIA) kits against HEV variants.
Summary:
- HEV RNA was detected in 23.4% of 64 non-A-E hepatitis sera using reverse transcriptase PCR (RT-PCR).
- Sequencing revealed two distinct HEV strains with 95% and 80% homology to the Chinese HEV strain.
- Anti-HEV seroconversion was observed in typical HEV infections but not in infections with HEV mutants within 1-3 months post-infection.
Impact:
- Identified HEV mutants that evade detection by commercial anti-HEV EIA kits.
- Suggests the need for improved diagnostic tools to detect diverse HEV strains.
- Contributes to understanding HEV epidemiology and diagnostic challenges.